Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Tranexamic acid and blood loss during and after cesarean section: a meta-analysis

Abstract

Objective:

A meta-analysis of randomized controlled trials (RCTs) was conducted to evaluate whether tranexamic acid (TXA) could significantly reduce blood loss during and after cesarean section (CS) when compared with no TXA.

Study design:

MEDLINE (PubMed), EMBASE, Cochrane Central Register of Controlled Trials and Web of Science were searched to identify RCTs that compared intravenous TXA with no TXA before CS for blood loss. The related data were extracted by two independent authors. The fixed or random-effect methods were used to combine data.

Result:

Eleven RCTs were included in this analysis with a total of 1276 women in TXA group and 1255 in no TXA (control) group. Total blood loss during and after CS was significantly less in TXA group than in control group (mean difference (MD) −141.61 ml, 95% confidence interval (CI) −207.09 to −76.14, P<0.01). There was a significant reduction in intraoperative and postpartum blood loss in TXA group as compared with control group (MD −143.36 ml, 95% CI −220.38 to −66.35, P<0.01; and MD −38.20 ml, 95% CI −59.27 to −17.12, P<0.01, respectively). Declines in hemoglobin and hematocrit values after CS were both significantly less in TXA group than in control group. The difference of postpartum hemorrhage rate was statistically significant between groups (risk ratio (RR) 0.57, 95% CI 0.37 to 0.89, P=0.01). The need for blood transfusion was significantly less in TXA group than control group (RR 0.23, 95% CI 0.10 to 0.57, P<0.01).

Conclusion:

Our results demonstrate that TXA offers an advantage over no TXA in reducing blood loss during and after CS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  1. Betran AP, Merialdi M, Lauer JA, Bing-Shun W, Thomas J, Van Look P et al. Rates of caesarean section: analysis of global, regional and national estimates. Paediatr Perinat Epidemiol 2007; 21 (2): 98–113.

    Article  Google Scholar 

  2. Menacker F, Hamilton BE . Recent trends in cesarean delivery in the United States. NCHS Data Brief 2010; 35: 1–8.

    Google Scholar 

  3. Mi J, Liu F . Rate of caesarean section is alarming in China. Lancet 2014; 383 (9927): 1463–1464.

    Article  Google Scholar 

  4. World Health Organization. The World Health Report, 2005: Make Every Mother and Child Count. World Health Organization: Geneva, 2005.

  5. Ekeroma AJ, Ansari A, Stirrat GM . Blood transfusion in obstetrics and gynaecology. Br J Obstet Gynaecol 1997; 104 (3): 278–284.

    Article  CAS  Google Scholar 

  6. AbouZahr C . Global burden of maternal death and disability. Br Med Bull 2003; 67: 1–11.

    Article  Google Scholar 

  7. Hoylaerts M, Lijnen HR, Collen D . Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta 1981; 673 (1): 75–85.

    Article  CAS  Google Scholar 

  8. Dunn CJ, Goa KL . Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999; 57 (6): 1005–1032.

    Article  CAS  Google Scholar 

  9. Gai MY, Wu LF, Su QF, Tatsumoto K . Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 2004; 112 (2): 154–157.

    Article  CAS  Google Scholar 

  10. Gohel M, Patel P, Gupta A, Desai P . Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: a randomized case controlled prospective study. J Obstet Gynecol India 2007; 57 (3): 227–230.

    Google Scholar 

  11. Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T, Tafti AD . Efficacy of tranexamic acid in reducing blood loss after cesarean section. J Matern Fetal Neonatal Med 2009; 22 (1): 72–75.

    Article  CAS  Google Scholar 

  12. Movafegh A, Eslamian L, Dorabadi A . Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery. Int J Gynaecol Obstet 2011; 115 (3): 224–226.

    Article  CAS  Google Scholar 

  13. Gungorduk K, Yildirim G, Asicioglu O, Gungorduk OC, Sudolmus S, Ark C . Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. Am J Perinatol 2011; 28 (3): 233–240.

    Article  Google Scholar 

  14. Halder S, Samanta B, Sardar R, Chattopadhyay S . Tranexamic acid used before caesarean section reduces blood loss based on pre- and postoperative haemoglobin level: a case-control study. J Indian Med Assoc 2013; 111 (3): 184–186.

    PubMed  Google Scholar 

  15. Goswami U, Sarangi S, Gupta S, Babbar S . Comparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment cesarean section: a double-blind randomized case control prospective trial. Saudi J Anaesth 2013; 7 (4): 427–431.

    Article  Google Scholar 

  16. Shahid A, Khan A . Tranexamic acid in decreasing blood loss during and after caesarean section. J Coll Physicians Surg Pak 2013; 23 (7): 459–462.

    PubMed  Google Scholar 

  17. Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gulmezoglu AM . Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. J Matern Fetal Neonatal Med 2013; 26 (17): 1705–1709.

    Article  CAS  Google Scholar 

  18. Senturk MB, Cakmak Y, Yildiz G, Yildiz P . Tranexamic acid for cesarean section: a double-blind, placebo-controlled, randomized clinical trial. Arch Gynecol Obstet 2013; 287 (4): 641–645.

    Article  Google Scholar 

  19. Xu J, Gao W, Ju Y . Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial. Arch Gynecol Obstet 2013; 287 (3): 463–468.

    Article  CAS  Google Scholar 

  20. Moher D, Liberati A, Tetzlaff J, Altman DG . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151 (4): 264–269.

    Article  Google Scholar 

  21. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17 (1): 1–12.

    Article  CAS  Google Scholar 

  22. Hozo SP, Djulbegovic B, Hozo I . Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13.

    Article  Google Scholar 

  23. Higgins JP, Thompson SG, Deeks JJ, Altman DG . Measuring inconsistency in meta-analyses. BMJ 2003; 327 (7414): 557–560.

    Article  Google Scholar 

  24. Hong S, Wang H, Yang S, Yang K . External stent versus no stent for pancreaticojejunostomy: a meta-analysis of randomized controlled trials. J Gastrointest Surg 2013; 17 (8): 1516–1525.

    Article  Google Scholar 

  25. Sterne JA, Egger M . Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001; 54 (10): 1046–1055.

    Article  CAS  Google Scholar 

  26. Egger M, Davey SG, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315 (7109): 629–634.

    Article  CAS  Google Scholar 

  27. Shakur H, Elbourne D, Gulmezoglu M, Alfirevic Z, Ronsmans C, Allen E et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 2010; 11: 40.

    Article  Google Scholar 

  28. As AK, Hagen P, Webb JB . Tranexamic acid in the management of postpartum haemorrhage. Br J Obstet Gynaecol 1996; 103 (12): 1250–1251.

    Article  CAS  Google Scholar 

  29. Yang H, Zheng S, Shi C . Clinical study on the efficacy of tranexamic acid in reducing postpartum blood lose: a randomized, comparative, multicenter trial. Zhonghua Fu Chan Ke Za Zhi 2001; 36 (10): 590–592.

    CAS  PubMed  Google Scholar 

  30. Ronsmans C, Graham WJ . Maternal mortality: who, when, where, and why. Lancet 2006; 368 (9542): 1189–1200.

    Article  Google Scholar 

  31. Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 2011; 15 (2): R117.

    Article  Google Scholar 

  32. Stafford I, Dildy GA, Clark SL, Belfort MA . Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol 2008; 199 (5): 511–519.

    Article  Google Scholar 

  33. Bekassy Z, Astedt B . Treatment with the fibrinolytic inhibitor tranexamic acid—risk for thrombosis? Acta Obstet Gynecol Scand 1990; 69 (4): 353–354.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H-M Yin.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, HY., Hong, SK., Duan, Y. et al. Tranexamic acid and blood loss during and after cesarean section: a meta-analysis. J Perinatol 35, 818–825 (2015). https://doi.org/10.1038/jp.2015.93

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2015.93

This article is cited by

Search

Quick links